Open AccessDoes tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious adverse reactions?
Author(s) -
Yong Wang,
Qing Mao,
Xiangdong Zhou
Publication year - 2020
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2009961117
Subject(s) - covid-19 , tocilizumab , adverse effect , human capital , medicine , medical education , business , psychology , virology , economics , economic growth , disease , outbreak , infectious disease (medical specialty)